1-vinylcyclohexanecarboxylic acid | 72335-94-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 1-vinylcyclohexanecarboxylic acid
• 英文别名: 1-ethenylcyclohexane-1-carboxylic acid；1-vinyl-1-cyclohexyl-carboxylic acid；1-Vinylcyclohexane-1-carboxylic acid
• CAS: 72335-94-5
• 化学式: C₉H₁₄O₂
• 分子量: 154.209
• InChiKey: SQZCJGGPRDQHHQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-vinylcyclohexanecarboxylic acid 在 草酰氯 、 Pd(OTf)₂ 、 三乙胺 、 5,5'-二(三氟甲基)-2,2'-联吡啶 作用下， 以 二氯甲烷 、 1,2-二氯乙烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 6.17h， 生成 (1-(bicyclo[4.2.0]octa-1⁽⁶⁾,2,4-trien-7-yl)cyclohexyl)(morpholino)methanone
  参考文献：
  名称：

  Pd(II)催化芳基硼酸与烯烃的氧化[2+2]环化合成苯并环丁烯,Pd(II)催化芳基硼酸与烯烃的氧化[2+2]环化合成苯并环丁烯,Pd(II)催化芳基硼酸与烯烃的氧化[2+2]环化合成苯并环丁烯

  摘要：

  苯并环丁烯 (BCB) 是有机合成、药物化学和材料科学中非常有价值的化合物。然而，从容易获得的起始材料催化模块化合成功能化 BCBs 仍然有限。我们在此报告了在N-氟苯磺酰亚胺 (NFSI)存在下通过 Pd(II) 催化的芳基硼酸和烯烃之间的形式 [2+2] 环化有效合成多种功能化的 BCB 。分子间碳钯化，然后是钯氧化，分子内 C(sp 2 )–H 由瞬态 C(sp 3)–Pd(IV) 物种，以及从高价五元钯环中选择性碳-碳 (C-C) 键形成还原消除来解释反应结果。烷基Pd(II) 到烷基Pd(IV) 物质的动力学有效氧化对于避免形成Heck 加合物很重要。该反应形成了环丁烯核心的两个 C-C 键，并与多种官能团相容。该转化不需要烯烃部分中的螯合双齿导向基团。,苯并环丁烯 (BCB) 是有机合成、药物化学和材料科学中非常有价值的化合物。然而，从容易获得的起始材料催化模块化合成功能化 BCBs

  DOI：

  10.1021/jacs.2c03565
• 作为产物：
  描述：

  环己乙炔 生成 1-vinylcyclohexanecarboxylic acid
  参考文献：
  名称：

  DERIEN, SYLVIE;CLINET, JEAN-CLAUDE;DUNACH, ELISABETH;PERICHON, JACQUES, SYNLETT.,(1990) N, C. 361-364

  摘要：

  DOI：

文献信息

• AMINOTHIAZOLONES AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS
  申请人：Bignan Gilles

  公开号：US20110200587A1

  公开（公告）日：2011-08-18

  The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating a condition including but not limited to ankylosing spondylitis, artherosclerosis, arthritis (such as rheumatoid arthritis, infectious arthritis, childhood arthritis, psoriatic arthritis, reactive arthritis), bone-related diseases (including those related to bone formation), breast cancer (including those unresponsive to anti-estrogen therapy), cardiovascular disorders, cartilage-related disease (such as cartilage injury/loss, cartilage degeneration, and those related to cartilage formation), chondrodysplasia, chondrosarcoma, chronic back injury, chronic bronchitis, chronic inflammatory airway disease, chronic obstructive pulmonary disease, diabetes, disorders of energy homeostasis, gout, pseudogout, lipid disorders, metabolic syndrome, multiple myeloma, obesity, osteoarthritis, osteogenesis imperfecta, osteolytic bone metastasis, osteomalacia, osteoporosis, Paget's disease, periodontal disease, polymyalgia rheumatica, Reiter's syndrome, repetitive stress injury, hyperglycemia, elevated blood glucose level, and insulin resistance.

  本发明涉及式(I)的化合物，制备这些化合物的方法，组合物，中间体及其衍生物，并用于治疗包括但不限于强直性脊柱炎、动脉粥样硬化、关节炎（如类风湿关节炎、感染性关节炎、儿童关节炎、银屑病性关节炎、反应性关节炎）、与骨相关的疾病（包括与骨形成有关的疾病）、乳腺癌（包括对抗雌激素治疗无效的癌症）、心血管疾病、软骨相关疾病（如软骨损伤/丧失、软骨退化以及与软骨形成有关的疾病）、软骨发育不全、软骨肉瘤、慢性背部损伤、慢性支气管炎、慢性炎症性气道疾病、慢性阻塞性肺病、糖尿病、能量稳态紊乱、痛风、假性痛风、脂质紊乱、代谢综合征、多发性骨髓瘤、肥胖、骨关节炎、遗传性骨发育不全、骨溶解性骨转移、软骨软化症、骨质疏松症、帕金森病、牙周病、多肌痛风、Reiter综合征、重复性应激损伤、高血糖、血糖水平升高和胰岛素抵抗等疾病的方法。
• SUBSTITUTED AMINOTHIAZOLONE INDAZOLES AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS
  申请人：BIGNAN Gilles

  公开号：US20110150864A1

  公开（公告）日：2011-06-23

  The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating a condition including but not limited to ankylosing spondylitis, artherosclerosis, arthritis (such as rheumatoid arthritis, infectious arthritis, childhood arthritis, psoriatic arthritis, reactive arthritis), bone-related diseases (including those related to bone formation), breast cancer (including those unresponsive to anti-estrogen therapy), cardiovascular disorders, cartilage-related disease (such as cartilage injury/loss, cartilage degeneration, and those related to cartilage formation), chondrodysplasia, chondrosarcoma, chronic back injury, chronic bronchitis, chronic inflammatory airway disease, chronic obstructive pulmonary disease, diabetes, disorders of energy homeostasis, gout, pseudogout, lipid disorders, metabolic syndrome, multiple myeloma, obesity, osteoarthritis, osteogenesis imperfecta, osteolytic bone metastasis, osteomalacia, osteoporosis, Paget's disease, periodontal disease, polymyalgia rheumatica, Reiter's syndrome, repetitive stress injury, hyperglycemia, elevated blood glucose level, and insulin resistance.

  该发明涉及式(I)的化合物，制备这些化合物的方法，组合物，中间体及其衍生物，并用于治疗包括但不限于强直性脊柱炎、动脉粥样硬化、关节炎（如类风湿性关节炎、感染性关节炎、儿童关节炎、银屑病性关节炎、反应性关节炎）、与骨相关的疾病（包括与骨形成有关的疾病）、乳腺癌（包括对抗雌激素治疗无效的癌症）、心血管疾病、软骨相关疾病（如软骨损伤/丧失、软骨退化以及与软骨形成有关的疾病）、软骨发育不良、软骨肉瘤、慢性腰部损伤、慢性支气管炎、慢性炎症性气道疾病、慢性阻塞性肺疾病、糖尿病、能量稳态紊乱、痛风、假性痛风、脂质紊乱、代谢综合征、多发性骨髓瘤、肥胖、骨关节炎、遗传性骨发育不全、骨转移性溶骨性转移、软骨软化症、骨质疏松症、帕金森病、牙周病、多肌痛风、Reiter综合征、重复性应激损伤、高血糖、血糖水平升高和胰岛素抵抗等疾病的条件。
• SUBSTITUTED THIAZOLIDINEDIONE INDAZOLES, INDOLES AND BENZOTRIAZOLES AS ESTROGEN-RELATED RECEPTOR-a MODULATORS
  申请人：Bignan Gilles

  公开号：US20110294780A1

  公开（公告）日：2011-12-01

  The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating a condition including but not limited to ankylosing spondylitis, artherosclerosis, arthritis (such as rheumatoid arthritis, infectious arthritis, childhood arthritis, psoriatic arthritis, reactive arthritis), bone-related diseases (including those related to bone formation), breast cancer (including those unresponsive to anti-estrogen therapy), cardiovascular disorders, cartilage-related disease (such as cartilage injury/loss, cartilage degeneration, and those related to cartilage formation), chondrodysplasia, chondrosarcoma, chronic back injury, chronic bronchitis, chronic inflammatory airway disease, chronic obstructive pulmonary disease, diabetes, disorders of energy homeostasis, gout, pseudogout, lipid disorders, metabolic syndrome, multiple myeloma, obesity, osteoarthritis, osteogenesis imperfecta, osteolytic bone metastasis, osteomalacia, osteoporosis, Paget's disease, periodontal disease, polymyalgia rheumatica, Reiter's syndrome, repetitive stress injury, hyperglycemia, elevated blood glucose level, and insulin resistance.

  本发明涉及式(I)的化合物，制备这些化合物的方法，组合物，中间体及其衍生物，并用于治疗包括但不限于强直性脊柱炎，动脉粥样硬化，关节炎（如类风湿关节炎，感染性关节炎，儿童关节炎，银屑病性关节炎，反应性关节炎），与骨相关的疾病（包括与骨形成有关的疾病），乳腺癌（包括对抗雌激素治疗无效的癌症），心血管疾病，软骨相关疾病（如软骨损伤/丧失，软骨退化以及与软骨形成有关的疾病），软骨发育不良，软骨肉瘤，慢性腰部损伤，慢性支气管炎，慢性炎症性气道疾病，慢性阻塞性肺疾病，糖尿病，能量稳态紊乱，痛风，假性痛风，脂质紊乱，代谢综合征，多发性骨髓瘤，肥胖，骨关节炎，遗传性骨发育不全，骨溶解性骨转移，软骨软化症，骨质疏松症，帕金森病，牙周病，多肌痛风，Reiter综合征，重复性应激损伤，高血糖，血糖水平升高和胰岛素抵抗等病症的方法。
• Copper-catalyzed C–C bond-forming transformation of CO₂ to alcohol oxidation level: selective synthesis of homoallylic alcohols from allenes, CO₂, and hydrosilanes
  作者：Yosuke Tani、Kazunari Kuga、Tetsuaki Fujihara、Jun Terao、Yasushi Tsuji

  DOI：10.1039/c5cc03932k

  日期：——

  A highly selective carbon-carbon bond-forming transformation of carbon dioxide (CO2) to the alcohol oxidation level has been disclosed. By employing a copper/bisphosphine catalyst system and hydrosilanes as the mild and...

  已经公开了二氧化碳（CO 2）到醇氧化水平的高选择性形成碳-碳键的转化。通过使用铜/双膦催化剂体系和氢硅烷作为温和和...
• Regioselective Copper-Catalyzed Carboxylation of Allylboronates with Carbon Dioxide
  作者：Hung A. Duong、Paul B. Huleatt、Qian-Wen Tan、Eileen Lau Shuying

  DOI：10.1021/ol4019375

  日期：2013.8.2

  In the presence of a Cu(I)/NHC catalyst, the reactions of allylboronic pinacol esters with CO2 (1 atm) are highly regioselective, giving exclusively the more substituted β,γ-unsaturated carboxylic acids in most cases. A diverse array of substituted carboxylic acids can be prepared via this method, including compounds featuring all-carbon quaternary centers.

  在Cu（I）/ NHC催化剂的存在下，烯丙基硼酸频哪醇酯与CO 2（1 atm）的反应具有很高的区域选择性，在大多数情况下，仅生成取代度更高的β，γ-不饱和羧酸。通过这种方法可以制备各种各样的取代羧酸，包括具有全碳季中心的化合物。